The Challenge of Change - Managing Excipients Control
Colorcon
| « Previous month | Next month » |
GE will drop the CodeLink array system in 2007 and close a US-based production facility.
Thermo Fisher Scientific has bought Cohesive, an advanced sample extraction and liquid chromatography products manufacturer.
Analytical laboratory LGC has set up an initiative to develop a new approach to training for analysts working in molecular laboratories, with a novel e-learning tool.
The UK's Department of Trade and Industry (DTI) has pledged its support to an ultrasound spectroscopy project conducted by LGC, to evaluate its potential as a Process Analytical Tool (PAT) for non-destructive testing, real time acquisition and potential on-line use.
German biotech company MediGene and Sanofi Pasteur have signed a deal to develop new monoclonal T cell receptors that the vaccine maker will use to develop and validate vaccines more efficiently.
Specialty pharmaceutical company CyDex has been boosted by the news that an intramuscular injection formulation of schizophrenia drug Abilify, which makes use of its Captisol solubility technology has been launched in the USA.
NNE and Fresenius ProServe yesterday announced they had reached an agreement by which NNE will acquire Fresenius' subsidiary, engineering company Pharmaplan GmbH.
Crucell yesterday announced it had received the first orders from US-headquartered Wyeth Biotech. The order represents the first move following the finalisation of the contract manufacturing agreement between the two companies at the end of 2005.
Innovative, non-invasive new ways of delivering insulin are poised to transform diabetes management, despite concerns about their safety and efficacy, according to new research.
Pharma company Medichem has announced it has passed a US Food and Drug Administration (FDA) inspection without any problem for the third consecutive time.
Introgen Therapeutics last week announced that it has been granted a European patent for the commercial production of adenoviral compositions.
Researchers have discovered that using nanotechnology could help reduce fatalities from drug overdoses, as nanoparticles can act as potential antidotes.
Medicated chewing gum company Fertin Pharma has announced a collaboration with the US Army Dental Research and Trauma Detachment (USADRT) on the first antimicrobial chewing gum to lower incidences of disease and non-battle related injuries among soldiers.
A UK based firm aims to take up the fight against drug counterfeiters with its innovative imaging and spectroscopy products. TeraView says its technology could aid regulators and law enforcement agencies screen for potentially lethal fake medicines.
Solvay has contracted Novasep to provide synthesis of two active pharmaceutical ingredients, following Novasep's decision to combine synthesis and processing expertise.
The directed evolution of enzymes can lead to more efficient tools for the synthesis of drug molecules.
Patheon last week announced its fourth quarter and end of year financial results after a tough year for the contract drug manufacturer.
Dr Reddy's Laboratories has boosted its ability to serve Western pharmaceutical markets with an increase in its manufacturing capacity for drug formulations.
Pharma company Shire has agreed with European regulators on labelling information for its ulcerative colitis drug Mezavant, a further step in the firm's ambition to capture more of the $1.6bn (€1.2bn) mesalazine market through its easy and effective delivery system.
Drug delivery company MonoSolRx has announced it has received a $38m (€29m) funding from an investment group, illustrating the appeal of the company's dissolving film technology.
New technology provides unprecedented opportunities for unbiased pathogen discovery.
Oral immuno-therapies offer a cure, rather than just relief, to millions of hayfever sufferers worldwide.
Synthetic extra-cellular fluid maintains cell function and life while increasing pre-clinical trial reproducibility.
The US Food and Drug Administration (FDA) has decided against restricting the use of drug-eluting cardiac stents after a two-day investigation into their potential to increase blood clots.
Dr Reddy's Laboratories has started first clinical trials of a "four-in-one" polypill clinical trial, which could revolutionise the cardiovascular drugs market.
Vion Pharmaceuticals has awarded a manufacturing agreement with Ohio based contract manufacturers Ben Venue Laboratories to produce its lead anticancer drug, Cloretazine (VNP40101M).
EU lawmakers have approved a new chemical law aimed at making producers and importers of chemicals prove that the substances they put on the market are safe for consumers - making it one of the most controversial laws in years.
Schott has reported a 15 per cent growth rate for its pharma packaging business, three times higher than the growth of the overall pharma industry.
Lonza Group and Solvay Pharmaceuticals have today announced a strategic long-term manufacturing alliance.
Roche has invested $20m in a new technology that has the potential to dramatically enhance the delivery of subcutaneous drugs by acting like a 'molecular machete'.
Schwarz Pharma has awarded an engineering and procurement contract to a Jacobs Engineering Group subsidiary for the development of a new active pharmaceutical ingredient (API) manufacturing facility in Ireland.
Pharmaceutical giant AstraZeneca has invested in a tablet manufacturing plant in Egypt, which could form a launching pad for an expansion into emerging markets.
Biologic drug manufacturing is slowly starting to take off in Singapore and is expected to be a key component of the country's drug manufacturing activity in the future.
The first radio frequency identification (RFID) tag that can resist gamma irradiation has been developed to track pharmaceutical products early on and throughout the supply chain.
Almost 130 jobs will be lost at BASF's Minden site as the company succumbs to growing pressure from the Asian generic active pharmaceutical ingredient (API) market.
US researchers have developed a novel delivery vehicle for siRNA, an up-and-coming technology for switching off genes in the body that could accelerate its use in drug development.
A new 'glass' making technique that improves stability and durability could lead to novel coatings and improvements in drug delivery, according to researchers at the University of Wisconsin-Madison and the National Institute of Standards and Technology (NIST) Centre for Neutron Research.
Biotech drugmaker Auxilium has temporarily suspended Phase III clinical trials to investigate a manufacturing problem with its new injectable enzyme batch, which could potentially cost the firm $1m (€750,000).
Oracle has bought US firm Tolas Healthcare Packaging in a bid to bolster its pharma packaging capabilities.
Fine chemicals maker Siegfried Holdings has agreed to sign over part of the production capacity of its Zofingen production plant to US biotech Celgene Corp in a collaboration worth €34.9m.
The US Senate has confirmed Andrew von Eschenbach as the official Commissioner of the Food and Drug Administration (FDA) after months of delay due to complaints about the regulator's oversight.
Dutch researchers have developed a new way of making a Parkinson's disease drug using an inexpensive ionic liquid method that could yield cost savings of €11.3 million per annum.
PerkinElmer strengthens its position in the cell analysis instrumentation market by acquiring Evotec Technologies for approximately €23m.
Baxter is expanding its lyophilisation capacity at its German facility to support future growth of its contract manufacturing business for anti-cancer drugs.
US biotechnology company Genzyme invests heavily in Lyon, boosting their biotech-production operations in Europe
Indian pharma firm Panacea Biotec has taken a 10 percent stake in UK-based vaccine maker Cambridge Biostability (CBL) for £1.9m (€1.4m) under a new joint venture deal signed between the two companies.
Phoqus pharmaceuticals reaches milestone in GSK deal on Qtrol, due to an increasing demand for drug delivery system.
Packaging maker Alcan has announced it will invest $27.5m (€20.7m) for an expansion project in its US pharma centre to meet the growing demand for pharmaceutical flexible packaging materials.
Nastech missed out on a $15m (€11m) milestone payment after having to delay the development of its new nasal spray for the treatment of osteoporosis because of the need of an additional clinical trial.
New flow reactor heater allows high-speed, multi-step reactions in front of your eyes allowing users to monitor progress and intervene in case problems to avoid time and reagent waste.
Biotech company Auxilium has decided to amend its manufacturing agreement with UK-based Cobra biologics in order to favour the in-house production of its new injectable enzyme.
A late night compromise on controversial EU legislation on chemical control - REACH - means it could now come into play as planned in 2007.
The UK subsidiary of ProMetic Life Sciences has signed a deal with Novartis to develop a new purification technology for recombinant protein vaccines that is claimed to be more efficient and cheaper than currently used methods.
Swiss custom manufacturer Lonza and Singapore's BioOne Capital have announced a new joint venture to build a $350m (€263m) large-scale manufacturing facility in Singapore.
Millipore has introduced a new container film - PureFlex - that ties in with the trend towards increasing use of disposable products within the bioprocessing sector.
A new cell culture process developed by Biolex Pharmaceuticals produces monoclonal antibodies which are both more potent and more effective.
AAIPharma has announced it has signed a contract manufacturing agreement with Mallinckrodt Pharmaceuticals Outsourcing which aims to provide a "one-stop drug development solution" for drug makers.
A hefty investment by Pfizer in an Irish manufacturing facility could prove to be a waste after the potential blockbuster it was designed to make has been canned.
Rockwood Holdings announced last week that it has reached an agreement to sell its subsidiary Groupe Novasep to a consortium of buyers in a transaction valued at €425m.
A US research company has published a report placing clamshell style packaging as the forerunner in the burgeoning high visibility packaging industry, with blister packs also on the increase.
Pharmaceutical giants push their flu vaccine production capacity to the limit but will it have an effect on future supply?
Canadian pharma manufacturer Bioxel has announced it has received several orders for its paclitaxel product - a taxane-based drug effective to treat cancer - from two European customers representing a total of CAD$630,000 (€420,000).
Cardinal Health, the leading contract manufacturer for the pharmaceutical industry, has announced its plans to sell its drug manufacturing and packaging unit in order to focus on its health-care business.
| « Previous month | Next month » |